From Name

From Email

To Name

To Email

Message

Prognostic Value of Donor-Derived, Cell‐Free DNA Assay in Acute Renal Rejection Therapy

from Clinical Transplantation

Prognostic Value of Donor-Derived, Cell‐Free DNA Assay in Acute Renal Rejection Therapy Clinical Transplantation Donor‐derived, cell‐free DNA (dd‐cfDNA) is a promising biomarker for monitoring allograft status. However, whether dd‐cfDNA can reflect real‐time anti‐rejection treatment effects remains unclear. Researchers prospectively recruited 28 patients with acute renal rejection, including 5 with ABMR, 12 with type IA or type IB rejection, and 11 with type IIA or IIB rejection. READ MORE

more